Investment

What does €100 million+ buy in European life sciences real estate?

Analysis of 31 transactions totalling €9 billion reveals investment patterns in European life sciences real estate in €100 million+ price range.
What does €100 million+ buy in European life sciences real estate?
Map shows location of deals worth €100 million+ over the last five years (source: proprietary deals database)
Table of Contents
In: Investment

In earlier editions we examined deals in the €5–10 million and €10–100 million ranges. Now we turn to the biggest of all: deals worth over €100 million.

An analysis of 31 transactions completed over the last five years, totalling €9 billion, reveals how investment patterns evolve at this scale. The numbers demonstrate which building typologies and markets dominate at these higher price points, while also showing a very broad range of investor types.

Deal sizes and investor behaviour

The deals range in value from just over the €100 million mark to €2 billion, with two-thirds of them falling into the €100 to €200 bracket. Almost half of the deals are for single buildings, leaving the other half split between single sites with multiple buildings (such as science parks or campuses) and portfolio deals.

Types of building

Point of care and R&D buildings make up the bulk of the deals, accounting for 68 per cent of the total deal count and 75 per cent of the volume.

More from Life Sciences Real Estate

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.